Sanofi News Headlines

Get SNY Alerts
*Delayed - data as of Sep. 23, 2014  -  Find a broker to begin trading SNY now
Exchange: NYSE
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By

There Is Further Upside Potential In Regeneron Pharmaceuticals
9/8/2014 1:23:00 PM - Seeking Alpha

Challenging Consensus On PCSK9 Inhibitors: Focus On Regeneron And Amgen
9/8/2014 11:39:00 AM - Seeking Alpha

Why Illumina (ILMN) Stock Is Gaining Today
9/8/2014 10:56:00 AM - TheStreet

Keryx Falls Victim To A Self-Fulfilling Prophecy, Creates Opportunity
9/8/2014 10:05:00 AM - Seeking Alpha

3 Reasons Sanofi's Stock Could Fall
9/8/2014 7:30:02 AM - Motley Fool

European ADRs Lower on as Telecom Companies Fall
9/5/2014 10:52:42 AM - MT Newswires

Amgen Seeks EU Approval for PCSK9 Inhibitor Evolocumab - Analyst Blog
9/4/2014 6:00:00 PM -

Sanofi Reports Positive Phase III Data on Dengue Vaccine - Analyst Blog
9/3/2014 6:40:00 PM -

Sanofi Should Be Part Of Your Portfolio If You Want Higher Returns
9/2/2014 6:17:00 PM - Seeking Alpha

WellPoint Leads The 20 Best Value Bond Trades With Maturities Of 1 Year Or More
9/2/2014 4:46:00 PM - Seeking Alpha

Regeneron/Sanofi Presents Encouraging Alirocumab Data - Analyst Blog
9/2/2014 4:30:00 PM -

Why Jim Cramer Likes Regeneron (REGN) Stock Over Sanofi (SNY)
9/2/2014 4:19:00 PM - TheStreet

Is It Time to Buy Pfizer Inc.'s Stock?
9/2/2014 1:32:09 PM - Motley Fool

How Will Regeneron Pharmaceuticals (REGN) Stock Be Affected By This Coverage?
9/2/2014 11:13:00 AM - TheStreet

Jim Cramer's Mad Dash: Regeneron to $400; Conn's a No-Touch
9/2/2014 10:48:00 AM - TheStreet

Regeneron Pharmaceuticals Inc. (REGN) Has Jumped To A New High On Study Results
9/2/2014 9:33:00 AM - RTT News

Great Cholesterol Drug Data From Regeneron Pharmaceuticals Inc. and Sanofi SA, but Read the Fine Pri
9/2/2014 8:00:03 AM - Motley Fool

Sanofi, Regeneron Report Positive Results From Four Pivotal Alirocumab Trials
8/31/2014 3:34:00 AM - RTT News

Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog
8/29/2014 6:30:00 PM -

Amgen Submits Regulatory Application for PCSK9 Inhibitor - Analyst Blog
8/29/2014 6:05:00 PM -

Return To Behemoth Stocks
8/27/2014 10:25:00 AM - Seeking Alpha

7 Things Regeneron Pharmaceuticals Inc.'s Management Wants You to Know
8/26/2014 9:56:04 PM - Motley Fool

Why I Bought Into Monday's Move In Regeneron
8/26/2014 11:16:00 AM - Seeking Alpha

European ADRs Up on Manufacturing Gains
8/26/2014 10:54:48 AM - MT Newswires

WellPoint Leads 20 Best Value Bond Trades With Maturities Of 1 To 5 Years
8/26/2014 12:20:00 AM - Seeking Alpha